Benedicto Crespo-Facorro, Professor
University Hospital Marqués de Valdecilla, IDIVAL, Department of Psychiatry, School of Medicine, University of Cantabria, CIBERSAM Centro Investigación Biomédica en Red Salud Mental, Santander, Spain.
5
5
2
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Scott W Woods, MD
Yale University
Shared therapeutic areas:
William Honer, MD
University of British Columbia
Shared therapeutic areas:
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Martha Sajatovic, MD
Case Western Reserve University
Shared therapeutic areas:
Imran Chaudhry, MD
University of Manchester
Shared therapeutic areas:
Brandon Gaudiano, PhD
Butler Hospital
Shared therapeutic areas:
Sanjeev Pathak, MD
Alkermes, Inc.
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Nobuhito Sanada
Otsuka Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
All 5 trials loaded